Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
25.81 USD | +2.14% | -1.41% | -16.72% |
Financials (USD)
Sales 2024 * | 357M | Sales 2025 * | 503M | Capitalization | 3.83B |
---|---|---|---|---|---|
Net income 2024 * | -723M | Net income 2025 * | -672M | EV / Sales 2024 * | 12.3 x |
Net Debt 2024 * | 553M | Net Debt 2025 * | 654M | EV / Sales 2025 * | 8.92 x |
P/E ratio 2024 * |
-5.59
x | P/E ratio 2025 * |
-6.6
x | Employees | 912 |
Yield 2024 * |
-
| Yield 2025 * |
-
| Free-Float | 98.91% |
Latest transcript on Insmed Incorporated
1 day | +2.14% | ||
1 week | -1.41% | ||
Current month | -4.87% | ||
1 month | -2.35% | ||
3 months | -5.80% | ||
6 months | +3.03% | ||
Current year | -16.72% |
Managers | Title | Age | Since |
---|---|---|---|
Will Lewis
CEO | Chief Executive Officer | 55 | 12-09-09 |
Sara Bonstein
DFI | Director of Finance/CFO | 43 | 20-01-30 |
Martina Flammer
CTO | Chief Tech/Sci/R&D Officer | 60 | 19-12-18 |
Members of the board | Title | Age | Since |
---|---|---|---|
Carol Schafer
BRD | Director/Board Member | 60 | 20-03-31 |
Al Altomari
BRD | Director/Board Member | 65 | 12-08-01 |
Melvin Sharoky
BRD | Director/Board Member | 73 | 01-04-30 |
Name | Weight | AuM | 1st Jan change | Investor Rating |
---|---|---|---|---|
0.26% | 0 M€ | 0.00% | - | |
0.25% | 0 M€ | 0.00% | - |
Date | Price | Change | Volume |
---|---|---|---|
24-04-24 | 25.81 | +2.14% | 2,740,799 |
24-04-23 | 25.27 | +4.81% | 2,130,480 |
24-04-22 | 24.11 | -0.86% | 3,275,530 |
24-04-19 | 24.32 | -1.94% | 5,534,539 |
24-04-18 | 24.8 | -5.27% | 2,300,029 |
Delayed Quote Nasdaq, April 24, 2024 at 04:00 pm EDT
More quotesEPS Revisions
1st Jan change | Capi. | |
---|---|---|
-16.72% | 3.83B | |
-1.51% | 104B | |
+3.22% | 97.42B | |
+1.14% | 22.2B | |
-16.53% | 21.23B | |
-8.49% | 18.33B | |
-42.33% | 16.35B | |
-20.09% | 15.06B | |
+5.47% | 13.98B | |
+28.85% | 11.66B |
- Stock Market
- Equities
- INSM Stock